Schonfeld Strategic Advisors LLC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 117 filers reported holding IMMUNOVANT INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q2 2023$1,052,360
+80.2%
55,475
+47.3%
0.01%
+50.0%
Q1 2023$584,137
-67.7%
37,662
-63.0%
0.01%
-60.0%
Q4 2022$1,806,684
+175.4%
101,785
-13.3%
0.02%
+200.0%
Q3 2022$656,000
+209.4%
117,424
+381.2%
0.01%
+150.0%
Q3 2021$212,000
-59.9%
24,400
-51.2%
0.00%
-66.7%
Q2 2021$529,000
-40.4%
50,000
-9.6%
0.01%
-45.5%
Q1 2021$887,000
+3.1%
55,303
+196.9%
0.01%
-8.3%
Q4 2020$860,000
-45.6%
18,629
-58.5%
0.01%
-60.0%
Q3 2020$1,581,000
-5.6%
44,912
-34.7%
0.03%
+36.4%
Q2 2020$1,674,000
+24.1%
68,800
-19.1%
0.02%
-33.3%
Q4 2019$1,349,00085,0000.03%
Other shareholders
IMMUNOVANT INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders